Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

Clinical trial results published by Lilly show that Tirzepatide could potentially be one of the most effective drugs ever developed for weight loss. Experts discuss...
​For the first time, Time in Range was used as the main outcome measured in a clinical trial for a diabetes medication. Read about the study results and implications.
Semglee may provide a cheaper alternative to Lantus (insulin glargine) – it costs $148 for five pre-filled insulin pens.
Learn more about how you can participate in this clinical trial from Novo Nordisk, testing whether a new once-weekly insulin injection, when combined with semaglutide,...
The diaTribe team is excited to cover all the latest news in diabetes technology and treatments, attending our first in-person diabetes conference in over two years!...
Metformin is the world’s most common diabetes medication and can improve diabetes management. Research suggests that metformin might lead to weight loss in certain...
The US Preventive Services Task Force (USPSTF) has updated its recommendations, encouraging prediabetes and type 2 diabetes screening for people with excess weight or...
What factors matter most ? Where do I focus effort? How do I use “ripple effects” and “IFTTT” (If This, Then That) thinking? How do I avoid getting frustrated?
The FDA approved Ozempic for a 2.0 mg dose, which was based on clinical trial data showing the higher dose led to a better A1C and to weight loss.
Early trial results found that SGLT-2 inhibitor Jardiance is highly effective at preventing and treating kidney disease in people with or without type 2 diabetes.
Provention Bio’s new injectable drug, which was recommended by an FDA committee for approval on May 25, 2021, has had a tumultuous journey through the FDA application...
Trying to learn how to lower morning blood sugar? Here are the reasons why your glucose levels rise in the morning and how you can keep them in range.
Civica, a nonprofit pharmaceutical company, announced plans to make generic insulin available for $30 per vial or $55 for five prefilled pens, regardless of insurance...
Wegovy, a once-weekly injectable medication (semaglutide), has been approved by the FDA to treat obesity and excess weight – conditions that can lead to type 2 diabetes...
US pharmaceutical companies and insulin manufacturers react to proposed legislation that would cap insulin costs and prevent significant rises in the costs of...
The program is predicted to save older Americans hundreds of dollars per year
The FDA approved Kerendia (finerenone) – a brand new drug which has been shown to slow the progression of chronic kidney disease for people with type 2 diabetes. The EU...
Products claiming to treat or even cure diabetes are everywhere, but do these so-called ‘cures’ really work? Spoiler alert: the answer is usually no. Treatments for...
Newly diagnosed with type 2 diabetes? Dr. Francine Kaufman answers some of the most commonly asked questions for teens with type 2 diabetes
Vabysmo, a new drug manufactured by Roche, was recently approved by the FDA to treat two common eye diseases. Find out more about this medication and how it might help...

Pages